Issues | Brain | Oxford Academic (2024)

Browse issues

Browse by volume

Issues | Brain | Oxford Academic (1)

Volume 147, Issue 6

June 2024

Cover image

Cover image

Issues | Brain | Oxford Academic (2)

Cover image: Ostriches in the Namib desert run compulsively ahead of cars even when there is no clear beneficial goal, but occasionally they stop to evaluate the situation. How people arbitrate between habitual and goal-directed actions is considered in. Brain. 2024; 147(6):2230–2244. (Image courtesy of Ammar Al-Chalabi).

ISSN 0006-8950

EISSN 1460-2156

Issue navigation


<Previous Next>

Editorial

Beyond ventral and dorsal streams: thalamo-cortical connections for subcortical language integration

Dorothee Saur

Brain, Volume 147, Issue 6, June 2024, Pages 1927–1928, https://doi.org/10.1093/brain/awae152

  • View article

Scientific Commentaries

The brain’s arbitration system and obsessive-compulsive disorder

Trevor W Robbins

Brain, Volume 147, Issue 6, June 2024, Pages 1929–1930, https://doi.org/10.1093/brain/awae133

This scientific commentary relates to ‘Neurocomputational model of compulsivity: deviating from an uncertain goal-directed system’ by Kim et al. (https://doi.org/10.1093/brain/awae102).

  • View article
Targeting excitatory:inhibitory network imbalance in Alzheimer’s disease

David Blum and Sabine Levi

Brain, Volume 147, Issue 6, June 2024, Pages 1931–1933, https://doi.org/10.1093/brain/awae146

This scientific commentary refers to ‘Seizures exacerbate excitatory: inhibitory imbalance in Alzheimer’s disease and 5XFAD mice’ by Barbour et al. (https://doi.org/10.1093/brain/awae126).

  • View article
The implications of amyloid-β pathology: only time will tell

Emma M Coomans and Rik Ossenkoppele

Brain, Volume 147, Issue 6, June 2024, Pages 1934–1936, https://doi.org/10.1093/brain/awae147

This scientific commentary refers to ‘Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer’s disease’ by Cody et al. (https://doi.org/10.1093/brain/awae116).

  • View article

Review Articles

The basal forebrain cholinergic system as target for cell replacement therapy in Parkinson’s disease

Anders Björklund and Roger A Barker

Brain, Volume 147, Issue 6, June 2024, Pages 1937–1952, https://doi.org/10.1093/brain/awae026

Degeneration of the basal forebrain cholinergic system is a major cause of cognitive impairments and dementia in patients with Parkinson’s disease. Björklund and Barker summarize the extensive experimental data in support of the idea that transplants of cholinergic neurons could be used to restore cognitive function.

  • View article
A neuroanatomical and cognitive model of impaired social behaviour in frontotemporal dementia

Matthew A Rouse and others

Brain, Volume 147, Issue 6, June 2024, Pages 1953–1966, https://doi.org/10.1093/brain/awae040

Rouse et al. propose an integrative neurocognitive model of controlled social behaviour that can explain the observed impairment of social behaviours in frontotemporal dementia. The model can also account for findings from other patient groups, including individuals with semantic dementia, and from studies of the healthy brain.

  • View article

Reports

Digenic Leigh syndrome on the background of the m.11778G>A Leber hereditary optic neuropathy variant

Beryll Blickhäuser and others

Brain, Volume 147, Issue 6, June 2024, Pages 1967–1974, https://doi.org/10.1093/brain/awae057

Blickhäuser et al. examine why certain individuals carrying specific mitochondrial DNA variants primarily associated with optic neuropathy experience exceptionally severe Leigh syndrome spectrum disease. They conclude that the co-occurrence of these variants with a second variant in an interacting gene causes the more severe phenotype.

  • View article
  • Supplementary data
Lesion network of oculogyric crises maps to brain dopaminergic transcriptomic signature

Bassam Al-Fatly and others

Brain, Volume 147, Issue 6, June 2024, Pages 1975–1981, https://doi.org/10.1093/brain/awae094

Al-Fatly et al. use lesion-network mapping to identify a network of brain regions involved in the pathophysiology of lesion-induced oculogyric crises, and show that the topography of the network overlaps spatially with the expression of dopamine receptor type 2 in the brain.

  • View article
  • Supplementary data

Original Articles

Broadening the clinical spectrum: molecular mechanisms and new phenotypes of ANO3-dystonia

Jirap*rn Ousingsawat and others

Brain, Volume 147, Issue 6, June 2024, Pages 1982–1995, https://doi.org/10.1093/brain/awad412

Anoctamin 3 (ANO3) belongs to a family of transmembrane proteins that form phospholipid scramblases and ion channels. Ousingsawat et al. identify an association between ANO3 variants and paroxysmal dystonia and investigate the underlying mechanisms.

  • View article
  • Supplementary data
Genetic analysis and natural history of Parkinson’s disease due to the LRRK2 G2019S variant

Matthew J Kmiecik and others

Brain, Volume 147, Issue 6, June 2024, Pages 1996–2008, https://doi.org/10.1093/brain/awae073

The LRRK2 G2019S variant is the most common cause of monogenic Parkinson’s disease. In a prospective longitudinal study, Kmiecik et al. find that genotyped LRRK2 G2019S carriers report a similar burden of motor symptoms to non-carriers with Parkinson’s disease, but fewer non-motor symptoms including cognitive difficulties and hyposmia.

  • View article
  • Supplementary data
Huntington’s disease affects mitochondrial network dynamics predisposing to pathogenic mitochondrial DNA mutations

Andreas Neueder and others

Brain, Volume 147, Issue 6, June 2024, Pages 2009–2022, https://doi.org/10.1093/brain/awae007

Neueder et al. reveal an accumulation of mitochondrial DNA mutations and impairments in mitochondrial quality control in fresh skeletal muscle samples from patients with Huntington’s disease. Accelerated mitochondrial ageing may thus be one of the biological signatures of Huntington’s disease, including in peripheral tissues.

  • View article
  • Supplementary data
Neurodevelopmental and synaptic defects in DNAJC6 parkinsonism, amenable to gene therapy

Lucia Abela and others

Brain, Volume 147, Issue 6, June 2024, Pages 2023–2037, https://doi.org/10.1093/brain/awae020

Abela et al. identify neurodevelopmental and synaptic vesicle recycling defects in a patient-derived neuronal cell model of early-onset DNAJC6 parkinsonism. Rescue of key cellular disease features using lentiviral DNAJC6 delivery demonstrates the utility and feasibility of a potential gene therapy approach.

  • View article
  • Supplementary data

Editor's Choice

Motor network gamma oscillations in chronic home recordings predict dyskinesia in Parkinson’s disease

Maria Olaru and others

Brain, Volume 147, Issue 6, June 2024, Pages 2038–2052, https://doi.org/10.1093/brain/awae004

Olaru et al. used neurostimulators with sensing capabilities to record over 900 h of motor cortex and basal ganglia activity from patients with Parkinson’s disease in their own homes, with wearable monitors providing scores of motor impairment. The results revealed a relationship between excessive gamma rhythms and dyskinesia.

  • View article
  • Supplementary data
Mitigation of TDP-43 toxic phenotype by an RGNEF fragment in amyotrophic lateral sclerosis models

Cristian A Droppelmann and others

Brain, Volume 147, Issue 6, June 2024, Pages 2053–2068, https://doi.org/10.1093/brain/awae078

Droppelmann et al. show that an N-terminal fragment of a protein called RGNEF (NF242) competes with RNA to interact directly with TDP-43. In fruit fly and mouse models of ALS, NF242 extended lifespan and reduced motor impairments, suggesting that this approach could be a promising therapeutic strategy for TDP-43 proteinopathies.

  • View article
  • Supplementary data
Imbalanced mitochondrial dynamics contributes to the pathogenesis of X-linked adrenoleukodystrophy

Nathalie Launay and others

Brain, Volume 147, Issue 6, June 2024, Pages 2069–2084, https://doi.org/10.1093/brain/awae038

Launay et al. identify abnormalities in mitochondrial dynamics, favouring increased mitochondrial fission, in models of the inherited neurodegenerative disorder, X-linked adrenoleukodystrophy. Targeting mitochondrial dynamics could be a new avenue for therapeutic intervention.

  • View article
  • Supplementary data
Neuropathy target esterase activity defines phenotypes among PNPLA6 disorders

James Liu and others

Brain, Volume 147, Issue 6, June 2024, Pages 2085–2097, https://doi.org/10.1093/brain/awae055

Biallelic pathogenic variants in PNPLA6, which encodes neuropathy target esterase (NTE), cause a broad spectrum of neurological disorders. Liu et al. show that NTE activity predicts neurological phenotypes among affected individuals, suggesting that PNPLA6 disorders are a continuous spectrum of pleiotropic phenotypes defined by the activity of NTE.

  • View article
  • Supplementary data
Toxic effects of mutant huntingtin in axons are mediated by its proline-rich domain

Scott T Brady and others

Brain, Volume 147, Issue 6, June 2024, Pages 2098–2113, https://doi.org/10.1093/brain/awad280

Brady et al. show that axonal toxicity of mutant huntingtin requires a proline rich domain (PRD) adjacent to the polyQ tract which contains SH3-binding motifs and which is normally sequestered in wildtype huntingtin. PolyQ expansion leads to PRD exposure, resulting in aberrant activation of a MAP kinase and axonal degeneration.

  • View article
  • Supplementary data
Morc2a variants cause hydroxyl radical-mediated neuropathy and are rescued by restoring GHKL ATPase

Hye Yoon Chung and others

Brain, Volume 147, Issue 6, June 2024, Pages 2114–2127, https://doi.org/10.1093/brain/awae017

Mutations in the Microrchidia CW-type zinc finger 2 (MORC2) gene give rise to Charcot-Marie-Tooth disease type 2Z, but the underlying mechanism is unclear. Chung, Lee et al. demonstrate in mice that Morc2a variants cause hydroxyl radical-mediated neuropathy and show that this can be rescued through AAV-based gene therapy.

  • View article
  • Supplementary data
Maf1 loss regulates spinogenesis and attenuates cognitive impairment in Alzheimer’s disease

Yingying Han and others

Brain, Volume 147, Issue 6, June 2024, Pages 2128–2143, https://doi.org/10.1093/brain/awae015

Han, Chen et al. show that the transcription factor Maf1 is upregulated in the hippocampus of patients with Alzheimer’s disease and in APP/PS1 mice. Maf1 regulates the expression of NMDAR1 by binding to the promoter of the Grin1 gene and could represent a potential therapeutic target for Alzheimer’s disease.

  • View article
  • Supplementary data

Editor's Choice

Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer’s disease

Karly A Cody and others

Brain, Volume 147, Issue 6, June 2024, Pages 2144–2157, https://doi.org/10.1093/brain/awae116

Cody et al. implement a novel time framework to characterize the accumulation of tau pathology and cognitive decline relative to amyloid onset in Alzheimer’s disease. Characterizing the temporal disease cascade with respect to amyloid explains a considerable amount of heterogeneity in early disease progression.

See Coomans et al. (https://doi.org/10.1093/brain/awae147) for a scientific commentary on this article.

  • View article
  • Supplementary data
Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer’s disease

Hyun-Sik Yang and others

Brain, Volume 147, Issue 6, June 2024, Pages 2158–2168, https://doi.org/10.1093/brain/awae034

Yang and Yau et al. studied blood markers of vascular health in older adults and found that the plasma levels of two proteins involved in blood vessel formation predicted future Alzheimer’s disease pathology and cognitive decline. The results suggest potential diagnostic and therapeutic targets in early-stage Alzheimer’s disease.

  • View article
  • Supplementary data
Seizures exacerbate excitatory: inhibitory imbalance in Alzheimer’s disease and 5XFAD mice

Aaron J Barbour and others

Brain, Volume 147, Issue 6, June 2024, Pages 2169–2184, https://doi.org/10.1093/brain/awae126

Barbour et al. report that seizures worsen cognitive decline and excitatory:inhibitory imbalance in patients with Alzheimer's disease. Chronic treatment with the mTORC1 inhibitor rapamycin rescued aspects of this imbalance in an Alzheimer’s disease mouse model, suggesting therapeutic promise for patients with a seizure history.

See Blum et al. (https://doi.org/10.1093/brain/awae146) for a scientific commentary on this article.

  • View article
  • Supplementary data
Disease-linked mutations in Munc18-1 deplete synaptic Doc2

Noah Guy Lewis Guiberson and others

Brain, Volume 147, Issue 6, June 2024, Pages 2185–2202, https://doi.org/10.1093/brain/awae019

Mutations in Munc18-1/STXBP1 cause encephalopathies, but the underlying disease mechanism is unclear. Guiberson et al. show that mutations in Munc18-1 not only affect Munc18-1 itself, but also deplete its interactor Doc2. The severity of this effect is dependent on the Munc18-1 mutation, which may explain symptom heterogeneity.

  • View article
  • Supplementary data
Localization of stuttering based on causal brain lesions

Catherine Theys and others

Brain, Volume 147, Issue 6, June 2024, Pages 2203–2213, https://doi.org/10.1093/brain/awae059

By studying the locations of lesions causing stroke-induced stuttering, Theys, Jaakkola et al. identify a common acquired stuttering network, centred around the left posterior putamen. This network is also associated with the severity of developmental stuttering, providing support for a shared neural basis across aetiologies.

  • View article
  • Supplementary data
Macroscopic changes in aquaporin-4 underlie blast traumatic brain injury-related impairment in glymphatic function

Molly Braun and others

Brain, Volume 147, Issue 6, June 2024, Pages 2214–2229, https://doi.org/10.1093/brain/awae065

Blast traumatic brain injury is associated with an increased risk of long-term neurological and psychiatric sequelae, but the underlying mechanisms are unclear. Using clinical and preclinical data, Braun et al. show that blast injury may impair the function of the glymphatic system, responsible for the removal of waste from the brain.

  • View article
  • Supplementary data
Neurocomputational model of compulsivity: deviating from an uncertain goal-directed system

Taekwan Kim and others

Brain, Volume 147, Issue 6, June 2024, Pages 2230–2244, https://doi.org/10.1093/brain/awae102

Kim et al. propose that compulsivity in obsessive-compulsive disorder results from reduced top-down control of a habit controller (the putamen) by a prefrontal arbitrator. Enhancing fronto-striatal connectivity could be a promising strategy for reducing compulsivity and improving adaptive decision-making.

See Robbins et al. (https://doi.org/10.1093/brain/awae133) for a scientific commentary on this article.

  • View article
  • Supplementary data
Multimodal study of multilevel pulvino-temporal connections: a new piece in the puzzle of lexical retrieval networks

Igor Lima Maldonado and others

Brain, Volume 147, Issue 6, June 2024, Pages 2245–2257, https://doi.org/10.1093/brain/awae021

Maldonado et al. use in vivo tractography and post-mortem dissections to study the connections joining the pulvinar to the temporal lobe. They describe four branches, including one parallel to the auditory radiations, and show by electrical stimulation in awake surgery that this branch has a causal role in lexical retrieval.

  • View article
  • Supplementary data
  • Front Matter
  • Table of Contents
  • Back Matter

All issues

Advertisem*nt

Email alerts

Advance article alerts

New issue alert

Subject alert

Receive exclusive offers and updates from Oxford Academic

RSS Feeds

RSS Feed - Latest Issue Only RSS Feed - Advance Articles RSS Feed - Open Access RSS Feed - Editor's Choice

  • Latest

  • Most Read

  • Most Cited

The expanding clinical and genetic spectrum of DYNC1H1-related disorders
Subcortical tau is linked to hypoperfusion in connected cortical regions in 4-repeat tauopathies
TRIM71 mutations cause a neurodevelopmental syndrome featuring ventriculomegaly and hydrocephalus
The immune system in Parkinson’s disease: what we know so far
Leriglitazone halts disease progression in adult patients with early cerebral adrenoleukodystrophy

Advertisem*nt

Issues | Brain | Oxford Academic (2024)

FAQs

What is the meaning of academic issues? ›

It is quite common for students to experience academic concerns at some point during college or throughout their college career. These concerns may involve: Poor study habits. Difficulty grasping course material. Test anxiety that leads to poor performance on exams.

Where can I find academic articles? ›

The 10 Best Academic Research Sources
  • Google Scholar. Looking for an academic article, thesis, or abstract? ...
  • JSTOR. ...
  • Library of Congress. ...
  • PubMed Central. ...
  • Google Books. ...
  • Science.gov. ...
  • Digital Commons Network. ...
  • ResearchGate.

Is Oxford Academic reputable? ›

Oxford publishes accurate and authoritative texts. And, the English spelling and vocabulary is not at all difficult to adapt to for American readers.

Is Oxford Academic Oxford University Press? ›

Oxford University Press's academic insights for the thinking world combine authority, innovation, and excellence.

What is an academic struggle? ›

These struggles can manifest in various forms, such as encountering difficult course content, experiencing anxiety and mental health issues, or facing obstacles in establishing oneself as an academic in a particular field.

What is issue in academic writing? ›

Lack of Clarity and Precision

One prevalent issue in academic writing is the lack of clarity and precision. It's crucial to express your ideas in a clear, concise manner to ensure that your message is easily understood by your audience.

What are academic sources? ›

An academic source, also known as a scholarly or peer reviewed source, is a source written by experts or authorities in a specific field of study. These are usually found in academic journals, but books and reports can also be considered academic sources.

What is an academic article? ›

Academic articles are written by professionals in a given field. They are edited by the author's peers and often take years to publish. Their language is formal and will contain words and terms typical to the field. The author's name will be present, as will their credentials.

How do you identify an academic article? ›

You can usually tell the difference because scholarly articles will have citations to their sources and a list of references. If the article does not have a reference list, you may want to think twice before using it as one of your scholarly sources. These reference lists will be at the very end of the article.

Is Harvard as good as Oxford? ›

Rankings: Based on global rankings, Oxford beats Harvard, however in national rankings, Harvard holds a better position. Thus, Oxford wins based on the global rankings here. Acceptance Rate: Harvard is more selective than Oxford, hence Oxford wins here by 16.8% against 3.59%.

Does Oxford have GPA? ›

Undergraduate qualifications

If your graduate course at Oxford requires a 'first-class undergraduate degree with honours' in the UK system, you will usually need a bachelor's degree with an overall grade of Class 1, 'A' or 80%, or a GPA of 3.7 out of 4.0.

What is the hardest college to get into at Oxford? ›

All Souls College

All Souls is the most elusive Oxford College and it takes no undergraduate students. In order to get in, graduate and postgraduate students apply for examination fellowships through “the hardest exam in the world”.

Who funds Oxford Academic? ›

The University of Oxford is a global, outward-facing university, whose core objectives of teaching and research are supported to a significant extent by donations and research funding.

Who owns the Oxford publication? ›

It is the second oldest university press after Cambridge University Press, which was founded in 1534. It is a department of the University of Oxford. It is governed by a group of 15 academics, the Delegates of the Press, appointed by the vice-chancellor of the University of Oxford.

Why is Oxford University credible? ›

The University of Oxford has an outstanding global reputation for its teaching, research and contributions to society. We combine rich history and tradition with the innovative and forward-thinking approach of a modern university.

What is the meaning of academic challenges? ›

Academic challenges refer to the difficulties and obstacles that undergraduate students face during their academic work. These challenges provide opportunities for students to engage in self-regulated learning processes and problem-solving strategies 1.

What is the meaning of academic difficulty? ›

Description. Underdeveloped study skills and habits. Underestimating the level of detail, difficulty, depth, or extent of knowledge needed to be successful in college compared to high school or technical school experiences. Underestimating time necessary to devote to studying outside of class to be successful.

What is your academic meaning? ›

Academic is used to describe things that relate to the work done in schools, colleges, and universities, especially work which involves studying and reasoning rather than practical or technical skills. Their academic standards are high. I was terrible at school and left with few academic qualifications.

What does its academic mean? ›

theoretical or hypothetical; not practical, realistic, or directly useful: an academic question; an academic discussion of a matter already decided. .

Top Articles
Latest Posts
Article information

Author: Jamar Nader

Last Updated:

Views: 5952

Rating: 4.4 / 5 (75 voted)

Reviews: 82% of readers found this page helpful

Author information

Name: Jamar Nader

Birthday: 1995-02-28

Address: Apt. 536 6162 Reichel Greens, Port Zackaryside, CT 22682-9804

Phone: +9958384818317

Job: IT Representative

Hobby: Scrapbooking, Hiking, Hunting, Kite flying, Blacksmithing, Video gaming, Foraging

Introduction: My name is Jamar Nader, I am a fine, shiny, colorful, bright, nice, perfect, curious person who loves writing and wants to share my knowledge and understanding with you.